Pre-clinical formulation development
The company provides pre-clinical formulation development as part of its in-vitro services.
Source: LinkedIn company description · Retrieved October 13, 2026
Next Breath provides contract services for pharmaceutical, biotech, and medical device companies bringing inhalation and nasal products to market.
The company provides in-vitro services spanning pre-clinical formulation development and analytical testing in support of regulatory agency submissions. The company describes its intended role as a liaison between drug-molecule innovators and inventors of pulmonary and nasal drug-delivery devices.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
Next Breath serves pharmaceutical, biotech, and medical device companies bringing inhalation and nasal products to market.
The company provides pre-clinical formulation development as part of its in-vitro services.
Source: LinkedIn company description · Retrieved October 13, 2026
The company provides analytical testing in support of submissions to regulatory agencies.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 2, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 19, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.